Serveur d'exploration Tocilizumab - Analysis (France)

Index « Mesh.i » - entrée « Treatment Outcome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Treatment Failure < Treatment Outcome < Tretinoin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 75.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000060 (2019) Marine Ibranosyan [France] ; Laetitia Beraud [France] ; Hélène Lemaire [France] ; Anne-Gaëlle Ranc [France] ; Christophe Ginevra [France] ; Sophie Jarraud [France] ; Ghislaine Descours [France]The clinical presentation of Legionella arthritis reveals the mode of infection and the bacterial species: case report and literature review
000067 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000069 (2019) Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France]Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
000089 (2019) Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
000091 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000103 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses
000107 (2019) Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raimon Sanmarti [Espagne] ; Min Bao [États-Unis] ; Jenny Devenport [États-Unis] ; Attila Pethö-Schramm [Suisse]Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis
000140 (2018) J. Broner [France] ; E. Arnaud [France][Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].
000145 (2018) Anaïs Huwart [France] ; Florent Garrigues [France] ; Sandrine Jousse-Joulin [France] ; Thierry Marhadour [France] ; Dewi Guellec [France] ; Divi Cornec [France] ; Maelenn Gouillou [France] ; Alain Saraux [France] ; Valérie Devauchelle-Pensec [France]Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab
000147 (2018) Alvise Berti [États-Unis] ; Divi Cornec [France] ; Jose R. Medina Inojosa [États-Unis] ; Eric L. Matteson [États-Unis] ; M Hassan Murad [États-Unis]Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index.
000149 (2018) Mathilde Leclercq [France] ; M. Le Besnerais [France] ; V. Langlois [France] ; N. Girszyn [France] ; Y. Benhamou [France] ; C. Ngo [France] ; H. Levesque [France] ; M. Muraine [France] ; J. Gueudry [France]Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
000150 (2018) Maxime Samson [France] ; Hervé Devilliers [France] ; Kim Heang Ly [France] ; François Maurier [France] ; Boris Bienvenu [France] ; Benjamin Terrier [France] ; Pierre Charles [France] ; Loïc Guillevin [France] ; Jean-François Besancenot [France] ; Eric Liozon [France] ; Anne Laure Fauchais [France] ; Romaric Loffroy [France] ; Christine Binquet [France] ; Sylvain Audia [France] ; Raphaèle Seror [France] ; Xavier Mariette [France] ; Bernard Bonnotte [France]Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
000151 (2018) Paul Decker [France] ; Pierre Olivier [France] ; Jessie Risse [France] ; Stéphane Zuily [France] ; Denis Wahl [France]Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
000161 (2018) Catherine Chapelon-Abric [France] ; David Saadoun [France] ; Isabelle Marie [France] ; Cloé Comarmond [France] ; Anne Claire Desbois [France] ; Fanny Domont [France] ; Léa Savey [France] ; Patrice Cacoub [France]Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review.
000194 (2018) Arsene Mekinian [France] ; Mathieu Resche-Rigon [France] ; Cloé Comarmond [France] ; Alessandra Soriano ; Joel Constans [France] ; Laurent Alric [France] ; Patrick Jego [France] ; Florian Busato [France] ; Matthieu Cabon [France] ; Robin Dhote [France] ; Lazaro Estibaliz [France] ; Isabelle Koné-Paut [France] ; Cédric Landron [France] ; Christian Lavigne [France] ; Bertrand Lioger [France] ; Martin Michaud [France] ; Marc Ruivard [France] ; Karim Sacre [France] ; Jacques Eric Gottenberg [France] ; Francis Gaches [France] ; Tiphaine Goulenok [France] ; Carlo Salvarani ; Patrice Cacoub [France] ; Olivier Fain [France] ; David Saadoun [France]Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
000195 (2018) Guillaume Moulis [France] ; Grégory Pugnet [France] ; Nathalie Costedoat-Chalumeau [France] ; Alexis Mathian [France] ; Gaëlle Leroux [France] ; Jonathan Boutémy [France] ; Olivier Espitia [France] ; Laurence Bouillet [France] ; Sabine Berthier [France] ; Jean-Baptiste Gaultier [France] ; Pierre-Yves Jeandel [France] ; Amadou Konaté [France] ; Arsène Mékinian [France] ; Elisabeth Solau-Gervais [France] ; Benjamin Terrier [France] ; Daniel Wendling [France] ; Fanny Andry [France] ; Camille Garnier [France] ; Pascal Cathébras [France] ; Laurent Arnaud [France] ; Aurore Palmaro [France] ; Patrice Cacoub [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Philippe Arlet [France] ; Maryse Lapeyre-Mestre [France] ; Laurent Sailler [France]Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
000197 (2018) Grant S. Schulert [États-Unis] ; Francesca Minoia [Italie] ; John Bohnsack ; Randy Q. Cron ; Soah Hashad [Libye] ; Isabelle Koné-Paut [France] ; Mikhail Kostik [Russie] ; Daniel Lovell [États-Unis] ; Despoina Maritsi [Grèce] ; Peter A. Nigrovic [États-Unis] ; Priyankar Pal [Inde] ; Angelo Ravelli [Italie] ; Masaki Shimizu [Japon] ; Valda Stanevicha [Lettonie] ; Sebastiaan Vastert [Pays-Bas] ; Andreas Woerner [Suisse] ; Fabrizio De Benedetti [Italie] ; Alexei A. Grom [États-Unis]Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
000240 (2017) Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raim N Sanmarti [Espagne] ; Min Bao [États-Unis] ; Corrado Bernasconi [Suisse] ; Attila Pethö-Schramm [Suisse]Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
000244 (2017) Dinesh Khanna [États-Unis] ; Christopher P. Denton [Royaume-Uni] ; Celia J F. Lin [États-Unis] ; Jacob M. Van Laar [Pays-Bas] ; Tracy M. Frech [États-Unis] ; Marina E. Anderson [Royaume-Uni] ; Murray Baron [Canada] ; Lorinda Chung [États-Unis] ; Gerhard Fierlbeck [Allemagne] ; Santhanam Lakshminarayanan [États-Unis] ; Yannick Allanore [France] ; Janet E. Pope [Canada] ; Gabriela Riemekasten [Allemagne] ; Virginia Steen [États-Unis] ; Ulf Müller-Ladner [Allemagne] ; Helen Spotswood [Royaume-Uni] ; Laura Burke [Royaume-Uni] ; Jeffrey Siegel [États-Unis] ; Angelika Jahreis [États-Unis] ; Daniel E. Furst [États-Unis]Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
000248 (2017) Romain Gastaldi [France] ; Aurélie Sicaud ; Philippe Gaudin ; Athan BailletPulmonary Pasteurellosis in a Patient Treated With Tocilizumab for Rheumatoid Arthritis.
000254 (2017) Michael B. Arnold [Canada] ; Dinesh Khanna [États-Unis] ; Christopher P. Denton [Royaume-Uni] ; Jacob M. Van Laar [Pays-Bas] ; Tracy M. Frech [États-Unis] ; Marina E. Anderson [Royaume-Uni] ; Murray Baron [Canada] ; Lorinda Chung [États-Unis] ; Gerhard Fierlbeck [Allemagne] ; Santhanam Lakshminarayanan [États-Unis] ; Yannick Allanore [France] ; Gabriela Riemekasten [Allemagne] ; Virginia Steen [États-Unis] ; Ulf Müller-Ladner [Allemagne] ; Helen Spotswood [Royaume-Uni] ; Laura Burke [Royaume-Uni] ; Jeffrey Siegel ; Angelika Jahreis ; Daniel E. Furst [États-Unis] ; Janet E. Pope [Canada]Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Mesh.i -k "Treatment Outcome" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Mesh.i  \
                -Sk "Treatment Outcome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Treatment Outcome
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021